• Market Access
  • Strategic Portfolio Planning and Technology Foresight
  • Health Technology Assessment
  • Health Economics and Outcomes Research (HEOR)
  • Multi-Criteria Decision Analysis (MCDA)
  • Modelling and Simulation

Previous ProHTA® work has fo¬≠cused on the evaluation of medical innovations (drugs and medical devices) in the area of

  • Stroke
  • Dementia
  • Prostate Cancer
  • Breast Cancer
  • Chronic Heart Failure